Venetoclax penetrates in cerebrospinal fluid and may be effective in chronic lymphocytic leukemia with central nervous system involvement
Gianluigi Reda,
Ramona Cassin,
Gabriela Dovrtelova,
Cristina Matteo,
Juri Giannotta,
Maurizio D’Incalci,
Agostino Cortelezzi,
Massimo Zucchetti
Affiliations
Gianluigi Reda
Hematology Unit, IRCCS Ca’ Granda Ospedale Maggiore Policlinico of Milan, Italy
Ramona Cassin
Hematology Unit, IRCCS Ca’ Granda Ospedale Maggiore Policlinico of Milan, Italy
Gabriela Dovrtelova
Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Italy;Department of Pharmacology, Faculty of Medicine, Masaryk University and International Clinical Research Center, St. Anne’s University Hospital Brno, Czech Republic
Cristina Matteo
Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Italy
Juri Giannotta
Hematology Unit, IRCCS Ca’ Granda Ospedale Maggiore Policlinico of Milan, Italy
Maurizio D’Incalci
Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Italy
Agostino Cortelezzi
Hematology Unit, IRCCS Ca’ Granda Ospedale Maggiore Policlinico of Milan, Italy
Massimo Zucchetti
Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Italy
